NXgenPort (NGP), has designed an innovative and transformative technology to maximize remote care in cancer patients requiring an implantable chemo-port catheter. Combining proven chemo-port efficacy with microchip and sensor technology, NGP measures, monitors and reports physiological body functions in vivo over the course of disease and treatment.
In this episode, Founder and CEO Kathy Skinner shares the details of how this port advances care for a very important patient population and how its quickly gaining momentum.
In this episode, host Tobin Arthur is joined by colleagues Katie Richardson, MD and Mike Schmanske interviewing startup Founder Kate Dilligan of Cooler Heads....
Alex Stone is the Founder/CEO of Pacific Echelon Security Services, one of the fastest growing security companies in the United States. The company is...
Yuri is a forward-thinking entrepreneur and thought leader who has a true passion for community and global impact projects. He has served in a...
